於前期研究中,液化澱粉芽孢桿菌(Bacillus amyloliqufaciens)amy-1的胞外多醣(exopolysaccharides, EPS)於動物實驗被發現具有抗發炎效果,但機制不明。於是本論文以人類單核球細胞株THP-1為模型,分析EPS對發炎中的巨噬細胞之抗發炎效果與分子機制。方法是以12-O-tetradecanoylphorbol (TPA)誘導THP-1細胞分化為M0期,再以lipopolysaccharides (LPS)誘導細胞分化為發炎狀態的M1期,分析LPS與EPS共處理時發炎的效果與機制。結果,EPS明顯抑制LPS所誘導的iNOS, TNF-α, IL-6等發炎因子的表現。EPS也抑制LPS所誘導的IκB kinase (IKK) / nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB)路徑的活化。同時EPS也抑制mitogen-activated protein kinase (MAPK)中ERK的活化,但較高濃度的EPS卻活化JNK及p38。另外,EPS能活化抗氧化酵素heme oxygenase-1 (HO-1)的表現,並抑制ROS的生成。研究更進一步的發現,EPS抗氧化的效果至少與活化p38有關。結論是,EPS能抑制LPS所引起的發炎反應,機制與IKK/ NF-κB路徑的抑制有關。同時EPS能藉由活化p38來活化保護性的抗氧化機制,以降低發炎對細胞的傷害。
The exopolysaccharides (EPS) of Bacillus amyloliqufaciens amy-1 were found to have anti-inflammatory effects in animal tests, but the underlying mechanism is unknown. Therefore, this study used the human monocyte cell line THP-1 as a model to investigate the anti-inflammatory effect and molecular mechanism of EPS on macrophages. The cells were induced to differentiate into M0 phase by 12-O-tetradecanoylphorbol (TPA). Lipopolysaccharides (LPS) was then used to induce the differentiation of THP-1 cells into the pro-inflammatory M1 phase. This model was used to analyze the effect of EPS. Consequently, EPS significantly inhibited LPS-induced expression of iNOS, TNF-α and IL-6. Meanwhile, EPS inhibited the activation of IκB kinase (IKK) /nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) pathway by LPS. Moreover, EPS also suppressed the activation of mitogen-activated protein kinase (MAPK), ERK, but higher concentrations of EPS activated JNK and p38. In addition, EPS activated the expression of the antioxidant enzyme heme oxygenase-1 (HO-1) and reduced the generation of ROS. Furthermore, it was found that the antioxidation effect of EPS is at least correlated with the activation of p38. In conclusion, EPS inhibits LPS-induced inflammation, and the underlying mechanism is associated with the suppression of the IKK/NF-κB pathway. Meanwhile, EPS activate the protective antioxidant pathway by activating p38 to reduce cellular damages caused by inflammation.